https://www.fhcrc.org/en/news/releases/rss2014-04-23T16:31:36.153ZNews Releases RSS FeedAdobe Experience ManagerVitamin D and its effect on weight loss examined in new study - Fred Hutchinson Cancer Research CenterA new study published online April 18 in the American Journal of Clinical Nutrition suggests that healthy or “replete” levels of vitamin D may be associated with weight loss in a certain segment of postmenopausal overweight women.https://www.fhcrc.org/en/news/releases/2014/04/vitamin-d-effect-on-weight-loss2014-04-22T17:23:33.000Z2014-04-22T17:23:33.000ZNew gene variant found that increases the risk of colorectal cancer from eating processed meat - Fred Hutchinson Cancer Research CenterA common genetic variant that affects one in three people appears to significantly increase the risk of colorectal cancer from the consumption of processed meat, according to study published today in PLOS Genetics.https://www.fhcrc.org/en/news/releases/2014/04/gene-variant-increases-colorectal-cancer-from-processed-meat2014-04-17T19:44:11.000Z2014-04-17T19:44:11.000ZBezos family donates $20 million to Fred Hutch to develop therapies that ‘melt’ cancer - Fred Hutchinson Cancer Research CenterFred Hutchinson Cancer Research Center scientists striving for new cancer cures — and the patients who stand to benefit from them — got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single contribution in Fred Hutch’s history.https://www.fhcrc.org/en/news/releases/2014/04/bezos-family-donates-twenty-million-to-fred-hutch-to-develop-therapies-that-melt-cancer2014-04-07T15:29:41.000Z2014-04-07T15:29:41.000ZFred Hutch provides money and mentorship to four local community health organizations to help build their capacity for health-disparities research - Fred Hutchinson Cancer Research Centerhttps://www.fhcrc.org/en/news/releases/2014/04/fred-hutch-provides-money-and-mentorship-to-four-local-community-health-organizations-to-help-build-their-capacity-for-health-disparities-research2014-04-01T19:16:39.000Z2014-04-01T19:16:39.000ZCancer prevention expert Anne McTiernan appointed to clinical trials advisory panel - Fred Hutchinson Cancer Research Centerhttps://www.fhcrc.org/en/news/releases/2014/03/cancer-prevention-expert-anne-mctiernan-appointed-to-clinical-trials-advisory-panel2014-03-31T20:31:31.000Z2014-03-31T20:31:31.000ZThe community ride to obliterate cancer is returning to SeattleObliteride participants will enjoy an epic experience and a scenic ride as they
pedal through the Puget Sound area this summer, while raising critical funds to help Fred Hutchinson Cancer Research Center obliterate cancer. All-new routes for the 25, 50, 100 and 150-mile rides have just been released. This year’s event will also include a 1-mile route for kids, so the whole family can get in on the fun.
The routes are designed so everyone, from beginners to experienced cyclists, can do their part to help end cancer Aug. 8-10, 2014.https://www.fhcrc.org/en/news/releases/2014/03/the-community-ride-to-obliterate-cancer-is-returning-to-seattle2014-03-26T17:11:07.000Z2014-03-26T17:11:07.000ZGetting ready to quit smoking? - Fred Hutchinson Cancer Research CenterThe time is right – you’re ready to quit smoking. Begin with just a click at WebQuit.org.
WebQuit is an online quit-smoking program and research study being conducted by researchers at Fred Hutchinson Cancer Research Center. The WebQuit study, which is funded by the National Cancer Institute, is testing two online quit-smoking programs to learn which one is most useful to help people quit.https://www.fhcrc.org/en/news/releases/2014/03/getting-ready-to-quit-smoking2014-03-24T23:24:44.000Z2014-03-24T23:24:44.000ZGlenda Gray appointed new president of South African Medical Research Council - Fred Hutchinson Cancer Research CenterHIV expert Dr. Glenda Gray, co-principal investigator of the HIV Vaccine Trials Network (HVTN), which is headquartered at Fred Hutchinson Cancer Research Center, has been named president of the South African Medical Research Council, the premier medical research organization and funder of medical research in South Africa. The appointment is effective April 1.https://www.fhcrc.org/en/news/releases/2014/03/glenda-gray-appointed-new-president-of-south-african-medical-research-council2014-03-20T22:15:09.000Z2014-03-20T22:15:09.000ZFred Hutchinson Cancer Research Center announces 2014 Harold M. Weintraub Graduate Student Award winnershttps://www.fhcrc.org/en/news/releases/2014/03/2014-weintraub-award-winners2014-03-10T20:55:35.000Z2014-03-10T20:55:35.000ZEarly detection helps manage a chronic graft-vs.-host disease complication - Fred Hutchinson Cancer Research CenterA simple questionnaire that rates breathing difficulties on a scale of 0 to 3 predicts survival in chronic graft-vs.-host disease, according to a study published in the March issue of Biology of Blood and Marrow Transplantation.https://www.fhcrc.org/en/news/releases/2014/03/early-detection-chronic-graft-vs-host-disease2014-03-06T21:17:35.000Z2014-03-06T21:17:35.000ZShop and dine to help fund women’s cancer research at Fred Hutch - Fred Hutchinson Cancer Research CenterShop & Dine to Make a Difference, now in its 11th year, lets shoppers and diners score deals at University Village while helping support women’s cancer research at Fred Hutchinson Cancer Research Center.https://www.fhcrc.org/en/news/releases/2014/02/shop-and-dine-to-help-fund-womens-cancer-research-at-fred-hutch2014-02-25T22:11:29.000Z2014-02-25T22:11:29.000ZFred Hutch, SCCA researchers receive Leaders in Health Care Awards - Fred Hutchinson Cancer Research CenterResearchers at Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) were recognized in several categories of Seattle Business Magazine’s 2014 Leaders in Health Care Awards, including the publication’s Lifetime Achievement Award, given to Frederick R. Appelbaum, M.D., executive vice president and deputy director of Fred Hutch and president of SCCA.
The awards honor individuals and organizations in Washington’s health care industry who have made significant contributions to health and well-being. The awards were presented February 24 at the Seattle Business Leaders in Health Care Awards ceremony held at Seattle’s Washington State Convention Center.https://www.fhcrc.org/en/news/releases/2014/02/fred-hutch-scca-researchers-receive-leaders-in-health-care-awards2014-02-25T18:43:28.000Z2014-02-25T18:43:28.000ZSelenium and vitamin E supplements can increase risk of prostate cancer in some men - Fred Hutchinson Cancer Research CenterA multi-center study led by Fred Hutchinson Cancer Research Center has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer. But importantly, this risk depends upon a man’s selenium status before taking the supplements.https://www.fhcrc.org/en/news/releases/2014/02/selenium-and-vitamin-e-supplements-can-increase-risk-of-prostate-cancer-in-some-men2014-02-21T21:44:15.000Z2014-02-21T21:44:15.000ZDismantling pancreas cancer’s armor - Fred Hutchinson Cancer Research CenterPancreas cancer is notoriously impervious to treatment and resists both chemotherapy and radiotherapy. It has also been thought to provide few targets for immune cells, allowing tumors to grow unchecked. But new research from Fred Hutchinson Cancer Research Center shows that pancreas cancer “veils” itself from the immune system by recruiting specialized immune suppressor cells. The research team also found that removing these cells quickly triggers a spontaneous anti-tumor immune response. https://www.fhcrc.org/en/news/releases/2014/02/dismantling-pancreas-cancers-armor2014-02-20T17:21:39.000Z2014-02-20T17:21:39.000ZNew drug shows promise in treating indolent non-Hodgkin lymphomas - Fred Hutchinson Cancer Research CenterSEATTLE – Slow-growing, or indolent, non-Hodgkin lymphomas are difficult to treat, with most patients relapsing repeatedly and the disease becoming increasingly resistant to therapy over time.
But a new drug made by Seattle-based Gilead Sciences Inc. appears to offer hope for fighting the disease, according to a study published online today in The New England Journal of Medicine in advance of its March 13 print issue.https://www.fhcrc.org/en/news/releases/2014/01/new-drug-shows-promise-in-treating-indolent-non-hodgkin-lymphomas2014-01-22T22:00:00.000Z2014-01-22T22:00:00.000ZFred Hutch, SCCA receive CEO Cancer Gold Standard accreditation - Fred Hutchinson Cancer Research CenterFred Hutchinson Cancer Research Center and its cancer treatment arm, Seattle Cancer Care Alliance (SCCA), each have earned CEO Cancer Gold Standard accreditation in recognition of their commitment to employee health.CEO Cancer Gold Standard accreditation calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. https://www.fhcrc.org/en/news/releases/2014/01/fred-hutch-scca-receive-ceo-cancer-gold-standard-accreditation2014-01-14T22:18:22.000Z2014-01-14T22:18:22.000ZResearchers develop tool to determine individual risk of prostate cancer overdiagnosis - Fred Hutchinson Cancer Research CenterStudies have found that prostate cancer is overdiagnosed in up to 42 percent of cases, prompting men to receive unnecessary treatment that can cause devastating side effects, including impotence and incontinence.https://www.fhcrc.org/en/news/releases/2014/01/researchers-develop-tool-to-determine-individual-risk-of-prostate-cancer-overdiagnosis2014-01-09T21:50:51.000Z2014-01-09T21:50:51.000ZGary Lyman of Duke University and Cancer Institute to co-lead Hutchinson Institute for Cancer Outcomes Research at Fred Hutchinson Cancer Research Center - Fred Hutchinson Cancer Research CenterThe Hutchinson Institute for Cancer Outcomes Research (HICOR), an innovative research institute based at Fred Hutchinson Cancer Research Center that is charged with evaluating and improving the effectiveness and value of cancer prevention and treatment strategies through collaborative research – including health-economic analyses – has hired Gary Lyman, M.D., M.P.H., of Duke University to serve as the Institute’s co-director.https://www.fhcrc.org/en/news/releases/2014/01/gary-lyman-of-duke-university-and-cancer-institute-to-co-lead-hutchinson-institute-for-cancer-outcomes-research-at-fred-hutchinson-cancer-research-center2014-01-08T18:21:01.000Z2014-01-08T18:21:01.000Z8 million lives saved over 50 years, study finds - Fred Hutchinson Cancer Research Centerhttps://www.fhcrc.org/en/news/releases/2014/01/eight-million-lives-saved-over-50-years-study-finds2014-01-07T21:00:00.000Z2014-01-07T21:00:00.000ZObliteride 2014 debuts with new routes and new ways to help end cancer - Fred Hutchinson Cancer Research CenterAfter a hugely successful and fun inaugural Obliteride 2013, Fred Hutchinson Cancer Research Center is gearing up for the second annual community fundraising bike ride to raise money to help end cancer. Rider registration for the Aug. 8-10, 2014 event opens today at Obliteride.org. Register early to hold your spot in Obliteride 2014.https://www.fhcrc.org/en/news/releases/2014/01/obliteride-2014-debuts-with-new-routes-and-new-ways-to-help-end-cancer2014-01-06T08:00:00.000Z2014-01-06T08:00:00.000Z